Germitec key facts
as of Oct 2026- Manufacturer of disinfection systems intended to develop hospital hygiene systems that radically simplify the lives of healthcare professionals in terms of safety, time and responsibility.
- Germitec is valued at approximately $137.0M as of Oct 2026 (last reported valuation).
- It has raised $77.0M; the latest was Later Stage VC ($30.0M) in Feb 2025.
- Notable investors include Kurma Partners, Turenne Groupe, AQUITI Gestion, Eurazeo, Financiere Arbevel — 8 tracked in total.
- Status: Privately Held (backing).
Germitec's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·Watch Germitec: the Monday email on marks, rounds and moves
Germitec funding rounds
No funding rounds for Germitec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Germitec valuation
Germitec's last reported valuation was $137 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
Germitec investors
8 investors are on record for Germitec, including Kurma Partners, Turenne Groupe, AQUITI Gestion and Eurazeo.
About Germitec
Manufacturer of disinfection systems intended to develop hospital hygiene systems that radically simplify the lives of healthcare professionals in terms of safety, time and responsibility. The company specializes in ultraviolet light high-level disinfection (UV-C HLD) for reprocessing non-lumen medical devices, enabling medical staff to change clinical practice in reducing cross-infection risk.
- Sector
- Healthcare
- HQ
- Bordeaux, France
- Founded
- 2005
- Employees
- 45
- Website
- germitec.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.